Skip to main content

and
  1. No Access

    Article

    Neural suppression of miRNA-181a in the kidney elevates renin expression and exacerbates hypertension in Schlager mice

    BPH/2J mice are a genetic model of hypertension with overactivity of the sympathetic nervous system (SNS) and renin–angiotensin system (RAS). BPH/2J display higher renal renin mRNA and low levels of its negati...

    Kristy L. Jackson, Cindy Gueguen, Kyungjoon Lim, Nina Eikelis in Hypertension Research (2020)

  2. Article

    Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes

    We determined whether empagliflozin altered renal sympathetic nerve activity (RSNA) and baroreflexes in a diabetes model in conscious rabbits.

    Cindy Gueguen, Sandra L. Burke, Benjamin Barzel, Nina Eikelis in Diabetologia (2020)

  3. No Access

    Article

    Renal nerves contribute to hypertension in Schlager BPH/2J mice

    Schlager mice (BPH/2J) are hypertensive due to a greater contribution of the sympathetic nervous system (SNS) and renin-angiotensin system (RAS). The kidneys of BPH/2J are hyper-innervated suggesting renal ner...

    Cindy Gueguen, Kristy L. Jackson, Francine Z. Marques in Hypertension Research (2019)

  4. Article

    Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans

    The baseline insulin data given in Table 1 for the placebo group were incorrectly reported as 51 ± 10 pmol/l instead of 48 ± 10 pmol/l. This mistake also impacts on data reported in Table 4.

    Rebecca K. C. Loh, Melissa F. Formosa, Nina Eikelis, David A. Bertovic in Diabetologia (2018)

  5. Article

    Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans

    Increasing brown adipose tissue (BAT) activity is a possible therapeutic strategy to increase energy expenditure and glucose and lipid clearance to ameliorate obesity and associated comorbidities. The thiazoli...

    Rebecca K. C. Loh, Melissa F. Formosa, Nina Eikelis, David A. Bertovic in Diabetologia (2018)

  6. No Access

    Article

    Hypothalamo-pituitary adrenal axis and sympatho-adrenal medullary system responses to psychological stress were not attenuated in women with elevated physical fitness levels

    It is not clear if higher levels of cardiorespiratory fitness are associated with lower hypothalamo-pituitary adrenal (HPA) axis and sympatho-adrenal medullary (SAM) system reactivity to psychological stress ...

    Sisitha U. Jayasinghe, Gavin W. Lambert, Susan J. Torres, Steve F. Fraser in Endocrine (2016)

  7. Article

    Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity

    Brown adipose tissue (BAT) activation increases energy expenditure and may have therapeutic potential to combat obesity. The primary activating and adaptive signal for BAT is via β-adrenergic signalling. We pr...

    Andrew L. Carey, Renata Pajtak, Melissa F. Formosa, Bruce Van Every in Diabetologia (2015)

  8. Article

    Progression of cardiovascular and endocrine dysfunction in a rabbit model of obesity

    In rabbits, mean arterial pressure (MAP) increases in response to fat feeding, but does not increase further with progressive weight gain. We documented the progression of adiposity and the alterations in endo...

    Gabriela A Eppel, James A Armitage, Nina Eikelis, Geoffrey A Head in Hypertension Research (2013)

  9. No Access

    Article

    Mediators of sympathetic activation in metabolic syndrome obesity

    The metabolic syndrome represents a major public health burden because of its high prevalence in the general population and its association with cardiovascular disease and type 2 diabetes. Accumulated evidence...

    Nora E. Straznicky, Nina Eikelis, Elisabeth A. Lambert in Current Hypertension Reports (2008)